Delivery Order SPE2DB20D2001-SPE2DB24FPLKE
Award Date
9/16/24
Potential Completion Date
9/17/24
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of GARDASIL 9 vaccine syringes (0.5mL) to the Defense Logistics Agency (DLA). The $8,433.22 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 9, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of GARDASIL 9 syringes (0.5 mL) to the Defense Logistics Agency (DLA). The $5,773.01 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 11, 2024 and was awarded on October 10, 2024. This is a delivery order contract without any set-aside requirements, indicating open competition. AmerisourceBergen holds...
This federal contract award is for the delivery of GARDASIL 9 SYRINGE 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $12,388.77 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of GARDASIL 9 syringes to the Defense Logistics Agency (DLA). The contract, valued at $8,083.90, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 26, 2024. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery...
This federal contract award is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, to the Defense Logistics Agency (DLA). The $4,684.52 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 15, 2022 and was awarded on August 12, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
This federal contract award is for the delivery of GARDASIL 9 syringes (0.5 mL) to the Defense Logistics Agency (DLA). The firm fixed-price contract, valued at $32,172.64, was awarded to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of GARDASIL 9 syringes to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,568.50 and is a delivery order contract with a firm-fixed price pricing type. The award date is November 4, 2024, and the ultimate completion date is November 5, 2024. The...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $7,141.46 Delivery Order from the Defense Logistics Agency (DLA) for GARDASIL 9 syringes. The contract has an ultimate completion date of November 29, 2024 and is a Firm Fixed Price agreement. This award is under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of GARDASIL 9 vaccine syringes to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 27, 2024, with a ceiling value of $8,362.00 and a completion date of December 30, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,274.75 firm-fixed-price delivery order is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of July 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...